MiMedx Group, Inc. Share Price & Technical Analysis
MDXG · $3.67 (+1.38%)
Healthcare / Biotechnology
$3.67
+1.38%
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, …
Price chart
Seasonality
May has 3 positive and 1 negative years (last 5 years shown)
9% return in May, 21% avg return in past 3 year May month.
-52% return in 2026, 55% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -25% | -4% | -17% | -15% | 9% | – | – | – | – | – | – | – | -52% |
| 25 | -9% | -2% | -8% | -9% | -3% | -5% | 18% | 0% | 0% | 12% | -8% | -1% | -17% |
| 24 | -7% | 5% | -7% | -19% | 11% | -4% | 7% | 5% | -13% | 15% | 33% | 3% | 28% |
| 23 | 39% | 26% | -28% | 12% | 55% | 14% | 21% | -7% | -3% | -10% | 20% | 14% | 154% |
| 22 | -18% | 2% | -13% | -15% | 0% | -10% | 0% | 6% | -17% | 3% | 7% | -15% | -70% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX, EPICORD, EPIXPRESS, CHORIOFIX, EMERGE, CELERA, REGENKIT WOUND GEL, and EPIEFFECT sheets for use as protective barriers that enables a healthcare provider to select an appropriate size graft based on the size of the wound to reduce product waste. Its surgical and other product offerings consist of AMNIOFIX, AMNIOBURN, AMNIOCORD, AXIOFILL, HELIOGEN, and AMNIOEFFECT for applications in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery, and various orthopedic repairs and reconstructions. The company's products are used in the areas of wound care, burn, and surgical fields in healthcare. It sells its products through direct sales force and independent sales agents, as well as to individual customers and independent distributors in the United States. The company has a strategic alliance with Vaporox, Inc. for the promotion of their wound care offerings. The company was founded in 2006 and is headquartered in Marietta, Georgia.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$530.99M
P/E ratio
17.82
52W high
$7.99
52W low
$3.03
Volume
8,96,549
Beta
1.46
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is MiMedx Group, Inc. share price today?
- MiMedx Group, Inc. (MDXG) last traded around $3.67 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does MDXG have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for MDXG. Download the app for real-time alerts.
- How can I analyze MiMedx Group, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.